Rohin Patel

Stock Analyst at JP Morgan

(2.21)

# 3,570

Out of 5,182 analysts

5

Total ratings

66.67%

Success rate

12.59%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Rohin Patel

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	HAE Haemonetics	Maintains: Neutral	$62 → $74	$60.48	+22.35%	3	Dec 12, 2025
	NPCE NeuroPace	Maintains: Overweight	$18 → $20	$17.25	+15.94%	2	Dec 10, 2025

Haemonetics

Dec 12, 2025

Maintains: Neutral

Price Target: $62 → $74

Current: $60.48

Upside: +22.35%

NeuroPace

Dec 10, 2025

Maintains: Overweight

Price Target: $18 → $20

Current: $17.25

Upside: +15.94%